A mutation in the PTEN gene or a downregulation of PTEN protein production are frequent occurrences in several types of cancer,15,16 and lead to activation of the AKT/mTOR signaling pathway, which is associated with a poor clinical prognosis. This evidence concerns the gene PTEN and cancer.